What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research

Por Williams, Annalynn M., Zent, Clive S., Janelsins, Michelle C.
Publicado no Br J Haematol (2016)

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score

Por Feldman, Darren R., Ardeshir-Rouhani-Fard, Shirin, Monahan, Patrick, Sesso, Howard D., Fung, Chunkit, Williams, Annalynn M., Hamilton, Robert J., Vaughn, David J., Beard, Clair J., Cook, Ryan, Zaid, Mohammad Abu, Lipshultz, Steven E., Einhorn, Lawrence H., Oeffinger, Kevin C., Travis, Lois B., Fossa, Sophie D.
Publicado no Clin Genitourin Cancer (2018)

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy

Por Fung, Chunkit, Sesso, Howard D., Williams, Annalynn M., Kerns, Sarah L., Monahan, Patrick, Abu Zaid, Mohammad, Feldman, Darren R., Hamilton, Robert J., Vaughn, David J., Beard, Clair J., Kollmannsberger, Christian K., Cook, Ryan, Althouse, Sandra, Ardeshir-Rouhani-Fard, Shirin, Lipshultz, Steve E., Einhorn, Lawrence H., Fossa, Sophie D., Travis, Lois B.
Publicado no J Clin Oncol (2017)